781
|
|
|
CUGBP Elav-like family member 2 |
BRUNOL3, CELF-2, CUG-BP2, CUGBP2, DEE97, ETR-3, ETR3, NAPOR |
Alzheimer disease, Attention deficit hyperactivity disorder, Biliary tract cancer, Breast cancer, Cancer, Cervical cancer, Color vision deficiency, Colorectal cancer, Neurodevelopmental disorder, Developmental and epileptic encephalopathy, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Follicular lymphoma, Gastric cancer, Hepatocellular carcinoma, Hodgkin lymphoma, Lung cancer, Major depressive disorder, Neurotic disorder, Non-hodgkins lymphoma, Non-specific syndromic intellectual disability, Obesity, Open angle glaucoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Prostatic neoplasms, Retinopathy, Retinoschisis, Rheumatoid arthritis, Schizophrenia, Scoliosis, Squamous cell carcinoma, Stevens-johnson syndrome, Substance abuseView all (22 more) |
782
|
|
|
CUGBP Elav-like family member 3 |
BRUNOL1, CAGH4, ERDA4, ETR-1, TNRC4 |
|
783
|
|
|
CUGBP Elav-like family member 4 |
BRUNOL4, CELF-4 |
Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Breast cancer, Obstructive pulmonary disease, Color vision deficiency, Neurodevelopmental disorder, Dementia, Developmental disability, Diverticulitis, Gastroesophageal reflux disease, Irritable bowel syndrome, Major depressive disorder, Migraine, Mood disorder, Neurotic disorder, Non-specific syndromic intellectual disability, Obesity, Schizophrenia, Diabetes mellitus type 2View all (5 more) |
784
|
|
|
CUGBP Elav-like family member 5 |
BRUNOL-5, BRUNOL5, CELF-5 |
|
785
|
|
|
Cadherin EGF LAG seven-pass G-type receptor 1 |
ADGRC1, CDHF9, FMI2, HFMI2, LMPHM9, ME2 |
Alzheimer disease, Bladder exstrophy, Developmental and epileptic encephalopathy, Epilepsy, Gastric cancer, Hydrops fetalis, Lymphatic malformation, Lymphoid leukemia, Neural tube defects, susceptibility to, Situs ambiguus, Walker-warburg syndrome, Yellow nail syndrome |
786
|
|
|
Cadherin EGF LAG seven-pass G-type receptor 2 |
ADGRC2, CDHF10, EGFL2, Flamingo1, MEGF3 |
Aneurysm, Aortic aneurysm, Aortic stenosis, Atrial fibrillation, Endometrial hyperplasia, Cancer, Cardiovascular disease, Cerebrovascular disorder, Ischemic heart disease, Congestive heart failure, Coronary artery disease, Diabetes mellitus, Hyperlipidemia, Lipoprotein lipase deficiency, Global developmental delay, Heart disease, Heart failure, Heart valve disease, Intellectual developmental disorder, Coronary syndrome, Large artery stroke, Major depressive disorder, Metabolic syndrome, Myocardial infarction, Myocardial ischemia, Orofaciodigital syndrome, Peripheral arterial disease, Peripheral vascular disease, Stroke, Diabetes mellitus type 2, Vascular diseaseView all (16 more) |
787
|
|
|
Cadherin EGF LAG seven-pass G-type receptor 3 |
ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2, RESDA1 |
|
788
|
|
|
Cell migration inducing hyaluronidase 1 |
CCSP1, CEMIP1, HYBID, KIAA1199, TMEM2L |
|
789
|
|
|
Cell migration inducing hyaluronidase 2 |
TMEM2 |
|
790
|
|
|
Centrosomal AT-AC splicing factor |
CCDC84, DLNB14, MVA4 |
|
